BacoMind® is a proprietary extract of Bacopa monnieri standardized to 9 bioactives.
Key Pointers
Clinically proven to tackle the early symptoms of dementia
Clinically proven to be safe for human consumption
Clinically validated to improve brain related outcomes in a multi-ethnic population
Backed by over 10 scientific publications
Compliant to global regulatory standards
Key Pointers
Clinically proven to tackle the early symptoms of dementia
Clinically proven to be safe for human consumption
Clinically validated to improve brain related outcomes in a multi-ethnic population
Backed by over 10 scientific publications
Compliant to global regulatory standards
Clinical Findings
2 published clinical studies including elderly subjects provide evidence that Bacomind® improves memory acquisition and retention, verbal memory and attention.
2 published clinical studies including young children demonstrate that Bacomind® improves learning, memory and cognitive performance
Bacomind® is clinically proven to reduce ADHD (Attention Deficit Hyperactivity Disorder) symptoms in Indian children
